Rwanda

in page functions
[French]
Total population (2015) 11,609,658
Birth cohort (2015) 362,559
Surviving Infants (surviving to 1 year per year, 2015) 346,048
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 31/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 42/1000
World Bank Index, IDA (2012) 3.84
Gross Nation Income (per capita US$, 2014) 650
Co-financing status (2016) Initial self-financing
No. of districts/territories (2014) 30

Gavi support for Rwanda

Type of support

Approvals

2001-2020 (US$)
(30 Nov 2015)

Commitments

2001-2020 (US$)
(30 Nov 2015)

Disbursements

2000-2015 (US$)
(30 Nov 2015)

% Disbursed

(30 Nov 2015)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Health system strengthening (HSS 1) $5,605,000 $5,605,000 $5,605,000 100%
Health system strengthening (HSS 2) $4,439,957 $10,339,970 $4,439,957 100%
HPV (NVS) $4,751,295 $6,160,295 $4,215,546 89%
Immunisation services support (ISS) $2,958,700 $2,958,700 $2,958,700 100%
Injection safety support (INS) $369,500 $369,500 $369,500 100%
IPV (NVS) $972,000 $1,563,500 $557,471 57%
Measles (NVS) $307,000 $473,000 $17,706 6%
Measles-Rubella (NVS) $3,549,500 $3,549,500 $3,622,489 102%
MR - Operational costs (OPC) $3,279,500 $3,279,500 $3,279,500 100%
Penta (NVS) $46,197,028 $47,700,028 $44,180,306 96%
Pneumo (NVS) $29,864,303 $33,654,803 $29,012,448 97%
Rotavirus (NVS) $25,696,686 $28,903,186 $20,419,280 79%
Vaccine Introduction Grant (VIG) $1,686,650 $1,686,650 $1,403,650 83%
Total $129,677,119 $146,243,632 $120,081,552

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Rwanda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 98%
M:F sex ratio at birth (2015) 1.02
Household survey: DTP3 coverage for male (2010) 97.10%
Household survey: DTP3 coverage for female (2010) 96.50%
Household survey: Last DTP3 survey (2010) 97%
% districts achieving > 80% DTP3 coverage (2014) 100%
% districts achieving < 50% DTP3 coverage (2014) 0%
MCV WHO/UNICEF estimates (2014) 98%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$18,056,307 $102,025,240

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Rwanda

31 January 2016

OAFLA 3

Gavi welcomes Global Ambassador for Immunisation Kikwete

Former Tanzanian President announces his commitment to “the health of the African continent”

23 January 2015

WEF 2015 ls

Gavi gains new partners at World Economic Forum

Four private sector partnerships announced in Davos.

21 January 2015

Gavi item

New private sector partners bring technical expertise and innovative finance to help save children’s lives

Gavi to leverage corporate patent royalties and local knowledge to improve vaccine delivery and injection safety in poor countries.

close icon

modal window here